Ketamine (Awakn Life Sciences)

N/A

Report date: 2025/02/11 14:52:36

Base Information

Drug NameKetamine (Awakn Life Sciences)
Drug Alias NameAWKN-001AWKN-P-001
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAwakn Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAwakn Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A